LexDanaLexDanabeta
Inventor

Lingjun Mao

Inventor
Hope, RI, US

Overview

3→
Patents
2006–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
C12NMicroorganisms or enzymes15%
C07BGeneral methods of organic chemistry8%
C07DHeterocyclic compounds8%
C07HSugars8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
C12YEnzymes8%
PatentTitleYear
11,091,489Crystalline forms of a triazolopyrimidine compound20217,205,283'Antisense oligonucleotides that inhibit expression of HIF-1'20077,122,527'Use of antisense oligonucleotides to inhibit the expression of human Akt-1'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2007Patents assigned to REXAHN CORP (2)· patent assignee history
2006–2007Based in Hope, RI, US· patent location history
2021Patents assigned to NOVARTIS AG (1)· patent assignee history
2021Based in Shanghai, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
REXAHN CORP22006–2007
NOVARTIS AG12021
Locations
LocationPatentsSpan
Hope, RI, US22006–2007
Shanghai, CN12021